Skip to main content
. 2023 Aug 23;12(8):1050–1059. doi: 10.21037/gs-23-61

Table 3. Complications of the treatment.

Characteristic RT (N=68) Non-RT (N=66) P value
Event of complications from autologous 10 (38.5) 9 (64.3) 0.12
Event of complications from implant only 23 (92.0) 19 (63.3) 0.02
Event of complications from combined reconstruction 15 (88.2) 7 (31.8) 0.001
Implant complications N=38 N=26 0.004
   Capsular contracture grade I–II 21 (55.3) 19 (73.1)
   Capsular contracture grade III–IV 16 (42.1) 7 (26.9)
   Extrusion/malposition 1 (2.6) 0
Flap complication 0.195
   Yes 25 (36.8) 16 (24.2)
   No 42 (61.8) 49 (74.2)
   NA 1 (1.5) 1 (1.5)
Follow-up time (months) 53.42±36.96 54.17±34.98 >0.05
Median time to complication (months) 36 41 <0.05
Last follow-up status 0.031
   Disease free and alive 47 (69.1) 57 (86.4)
   Alive with locoregional recurrence 6 (8.8) 3 (4.5)
   Alive with locoregional recurrence 1 (1.5) 2 (3.0)
   Dead 11 (16.2) 1 (1.5)
   Loss to follow-up 3 (4.4) 3 (4.5)

Continuous variables are presented as mean ± SD and categorical data are presented as n (%). RT, radiotherapy; NA, not applicable; SD, standard deviation.